4.6 Editorial Material

Preparing for the age of therapeutic trials in frontotemporal lobar degeneration

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 93, Issue 2, Pages 115-115

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2021-327497

Keywords

frontotemporal dementia; primary progressive aphasia; randomised trials

Funding

  1. NIH [R01-NS109260, P01-AG066597, P30-AG10124, U19-AG062418]
  2. Penn Institute on Aging

Ask authors/readers for more resources

Therapeutic development for familial forms of FTLD is rapidly growing, and there is a need for adequate clinical tools to measure treatment effect, as addressed by Peakman et al.
There is a rapidly growing field of therapeutic development for familial forms of FTLD and Peakman et al address the important need for adequate clinical tools to measure treatment effect.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available